Colorado BioScience Association Announces 2014 BioWest Venture Showcase Finalists
Summary
The three finalists in the 2014 Venture Showcase competition at BioWest include: dBMEDx, Littleton; KromaTiD, Inc., Fort Collins; Mighty Oak Medical, Englewood.The conference features speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (her ‘Update on the FDA’ keynote will occur at 4:45 p.m.) and keynote panelists; Jandel Allen-Davis, M.D., Vice President, Government and External Relations, Kaiser Permanente Colorado; James Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine; Len Tacconi, President, HMR Weight Management Services Corp., a subsidiary of Merck & Co. Inc.; and Russell Slifer, Director, United States Patent & Trademark, Rocky Mountain Regional Office.The winner, announced at the end of the conference day, will receive a $7,500 cash prize.The three finalists in the 2014 Venture Showcase competition include:dBMEDx - LittletondBMEDx is developing breakthrough, real-time clinical decision and patient monitoring devices using our patented, non-invasive scanning technology.Visit: http://www.dbmedx.com.KromaTiD, Inc. - Fort CollinsKromaTiD is dedicated to creating new products for disease research, mutation detection and chromosome analysis.Visit: http://www.mightyoakmedical.com.About BioWest 2014 | September 10, 2014The BioWest Conference is a one day event attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs.The conference features speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (her ‘Update on the FDA’ keynote will occur at 4:45 p.m.) and keynote panelists; Jandel Allen-Davis, M.D., Vice President, Government and External Relations, Kaiser Permanente Colorado; James Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine; Len Tacconi, President, HMR Weight Management Services Corp., a subsidiary of Merck & Co. Inc.; and Russell Slifer, Director, United States Patent & Trademark, Rocky Mountain Regional Office.